Population pharmacokinetic and pharmacodynamic analysis of osimertinib.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e20536
Abstract: e20536Background: Osimertinib is an oral, potent, irreversible, CNS active EGFR-TKI, selective for sensitizing (EGFRm) and T790M resistance mutations, indicated for the treatment of patients with T... read more here.
Keywords: analysis osimertinib; pharmacodynamic analysis; population pharmacokinetic; pharmacokinetic pharmacodynamic ... See more keywords